Upon recommendation by underwriters’ counsel, members of CRA’s accounting and advisory team assisted a US-based bio-technology company in advance of its IPO by advising on existing compliance procedures, tightening financial controls, and enhancing internal reporting, governance, and risk management functions. CRA team members recommended and implemented both qualitative and systems-based solutions designed to address regulatory requirements.
Compliance solutions for pandemic-related fraud risks
When the COVID-19 pandemic struck the US in March 2020, office environments, supply chains and traditional ways of doing business evaporated in mere weeks....